Amneal Pharmaceuticals AMRX is gearing up to announce its quarterly earnings on Friday, 2024-11-08. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Amneal Pharmaceuticals will report an earnings per share (EPS) of $0.13.
The announcement from Amneal Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Past Earnings Performance
Last quarter the company beat EPS by $0.02, which was followed by a 0.0% drop in the share price the next day.
Here's a look at Amneal Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | 0.14 | 0.09 | 0.09 | 0.13 |
| EPS Actual | 0.16 | 0.14 | 0.14 | 0.19 |
| Price Change % | -2.0% | 9.0% | -1.0% | -6.0% |
Tracking Amneal Pharmaceuticals's Stock Performance
Shares of Amneal Pharmaceuticals were trading at $8.5 as of November 06. Over the last 52-week period, shares are up 102.96%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Amneal Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
